Neighbors a World Apart Nfant Mor- Reflection of National Health

Total Page:16

File Type:pdf, Size:1020Kb

Neighbors a World Apart Nfant Mor- Reflection of National Health 34 O B .GYN. NEWS • April 1, 2005 M ASTER C LASS Neighbors a World Apart nfant mor- reflection of national health. we may do well to learn from other coun- the University ofOttawa. He has studied tality is one Leaders in the medical community and tries’ successes. The Scandinavian coun- infant mortality as an international issue, Iofthe government have long recognized that tries, which boast very low infant mortal- publishing on such topics as population- dominant the United States has unacceptably high in- ity, have homogeneous populations that based approaches to prevention of measures by fant mortality in comparison with other are difficult to compare with our own. But preterm birth, an important contributor to which a na- nations. I served, in fact, on the Depart- right next door is Canada, a country with infant mortality. BY E. ALBERT REECE, tion’s health is ment ofHealth and Human Services’ Sec-an increasingly diverse population that We hope his thoughts will provide fresh M.D., PH.D, M.B.A. judged. Many retary’s Committee on Infant Mortality may serve as a more analogous example of insight into a very important health mea- factors con- under President George H.W. Bush, as how programs can work to reduce infant sure that we continue to try to improve.■ tribute to the number ofbabies who sur-part ofa major effort to reduce by halfour mortality. vive in a given country, making infant infant mortality. We still have not suc- For a commentary on this important is- DR. REECE, who specializes in maternal- mortality a rather unrefined gauge of ceeded, despite concerted efforts. sue, we turn to C. Robin Walker, M.D., fetal medicine, is the vice chancellor and overall health. Yet it has been accepted Because this is a complex issue that will Ch.B., president ofthe Canadian Paedi-dean of the college of medicine at the worldwide as a generally fair and realistic be solved only by using multiple strategies, atric Society and professor of pediatrics at University of Arkansas in Little Rock. Infant Mortality in the U.S. and Canada nfant mortality is a complex issue, in- ing to two basic contributors: neonatal We understand that older women have hardly ever see quads, although triplets are fluenced by social, statistical, political, deaths occurring within the first month of a higher risk ofhaving a preterm baby, stillin not a rarity. Iand geographic factors as well as med- life, and postneonatal deaths occurring part because they have a higher risk of All over Canada, rates ofmultiple birth ical ones. Looking at a chart ofinterna-later in the first year. having multiples, having pregnancy com- are lower than in the United States, con- tional infant mortality, one can see that the Postneonatal deaths have not increased; plications, and having babies with con- tributing to lower rates ofpreterm birth. United States, as well as my native Cana- in fact, tremendous advances in the under- genital anomalies, three factors that con- However, in looking at overall preterm da, are light-years better off than politically standing and prevention ofsudden infant tribute to infant mortality. birth statistics, it is worth noting that unstable regions such as Angola, which death syndrome have substantially reduced Older mothers also are more likely to re- both nations have unequal rates across leads the world at more than 191 infant postneonatal deaths over the past decade. quire assisted reproductive technology populations. deaths per 1,000 live births, or Afghanistan The neonatal increases noted in 2002— (ART). The U.S. National Center for Health Sta- (163 per 1,000), by estimates ofthe Cen-and indeed the disparity between the Although ART procedures are similar in tistics reports that African American infants tral Intelligence Agency’s United States and Canada— the United States and Canada, and are ba- are nearly twice as likely as non-Hispanic “World Factbook 2004.” have occurred in the early sically patient-funded in both countries, white infants to be born prematurely. However, we’re far from weeks oflife, when the most reproductive technology is increasingly In Canada, the disparity is most clear being the best in the world. common causes ofdeath in- subject to oversight in Canada. A bill that when looking at income, with those in Forty nations surpass the clude congenital anomalies, recently passed both the House ofCom-the lowest income quintile having an in- United States in infant mor- problems oftransition, and mons and the Senate would strictly regu- fant mortality rate two-thirds higher than tality, including Singapore complications ofpreterm late clinics and procedures, for example. that ofthe highest income quintile. As in- (2.29 per 1,000), Sweden birth. Among these factors, A great many ART centers in Canada fant mortality secondary to congenital (2.77 per 1,000), and Japan only preterm birth stands are university-affiliated, not-for-profit pro- anomalies and other causes has fallen (3.26 per 1,000). out as a significant contribu- grams, rather than independent clinics. As significantly, the differential is largely a re- Because we are neighbors tor to rising infant mortality. a result, a controversial issue—such as the sult ofa higher rate ofpreterm birth in and share a border, similar In the United States, implantation ofmultiple embryos—is de- lower-income families. economies, and comparable BY C. ROBIN preterm births increased to bated within the wide academic commu- Canada’s First Nation and Inuit people levels oftechnologic sophis- WALKER, M.D. 12.1%, from 11.9% the pre- nity ofendocrinologists, ob.gyns., neona- face serious health problems, including in- tication, it may be ofinter- vious year. tologists, pediatricians, and ethicists. fant mortality in many communities that is est that Canada’s infant mortality is fully But here is a telling statistic: Although When three sets ofquadruplets weretwice the national rate, as do America’s Na- 30% lower than that ofthe United States,the preterm birth rate also rose slightly in born in 1 year at the University ofOttawa,tive American populations. Although Cana- which was optimistically estimated by the Canada, it was 7.6% in 2002, nearly 40% the university-affiliated fertility center da is an increasingly racially diverse coun- CIA to be 6.5 per 1,000 in 2004. lower than in the United States. demonstrated its responsibility by revising try, other racial disparities are less obvious In both ofour nations, 2002 infant mor- Why is the preterm birth rate trending its policies to limit the number ofembryosin measures ofhealth care, such as prena- tality worsened slightly, prompting re- upward? The evidence is fairly clear that transferred during each cycle. Now, we Continued on following page newed scrutiny ofan ever-important issue. it is driven by the use ofreproductive tech- The Centers for Disease Control and nology leading to multiple births, by Prevention reported that in 2002, U.S. in- mothers having babies at later ages, by ob- Sources fant mortality edged upward to 7.0 per stetricians intervening to deliver babies 1,000 live births from 6.8 per 1,000 in 2001. earlier when the fetus is in jeopardy, and Ǡ The National Center for Health Canada has published the 2003 Canadi- That’s the first rise in 44 years, and even by complications attributed to a lack of Statistics publishes regular reports on an Perinatal Health Report online at if—as preliminary reports suggest—it was early, consistent prenatal care. infant mortality. The final data for www.phac-aspc.gc.ca/publicat/ a one-time blip, it’s concerning to see even Not all ofthese factors are things we2002 can be found in Natl. Vital Stat. cphr-rspc03. a 0.02% increase in the context ofmorecan, or would want to, control. Rep. 2003;52:1-113. The center’s latest Ǡ The United Nations Children’s Fund than 4 million births. Early delivery to attempt to save an in- annual report on trends in health sta- (UNICEF) uses data collected in annu- The same trend occurred in Canada, fant in trouble is a good thing. Some of tistics is “Health, United States, al report cards from its Innocenti Re- where infant mortality rose from 5.2 per these preemies will not live, but would 2004,” which includes a chartbook on search Centre. The first report card 1,000 in 2001 to 5.4 per 1,000 in 2002 after have been stillborn in years past. trends in the health ofAmericans as was published in June 2000, and— progressively falling since the 1960s. Social trends influence the ages at which well as interactive links (www.cdc. along with more recent report cards— I’d like to suggest a number offactorswomen decide to have their children. In gov/nchs/hus.htm). can be accessed at www.unicef-icdc. that may help to explain this troubling Ottawa, where I practice, over 60% of Ǡ The Central Intelligence Agency pub- org/publications. Click on the link trend, which at the very least indicates we moms in 2003 gave birth when they were lishes the World Factbook each year in “For a briefdescription ofour series,” are not making the progress we would like older than 30 years, and 23.2% when they printed and Internet versions. Data not- and then click on “Innocenti Report to make in addressing one ofthe most im-were older than 35 years. Although ed in this Master Class can be found on- Cards.” portant measures ofa nation’s health. women have a right to be informed about line at www.cia.gov/cia/publications/ Ǡ Simon Hales, M.B., and colleagues I’ll also put forth some suggested ex- their chances ofconceiving and delivering factbook/rankorder/2091rank.html.
Recommended publications
  • Update on Challenging Disorders of Pigmentation in Skin of Color Heather Woolery-Lloyd, M.D
    Update on Challenging Disorders of Pigmentation in Skin of Color Heather Woolery-Lloyd, M.D. Director of Ethnic Skin Care Voluntary Assistant Professor Miller/University of Miami School of Medicine Department of Dermatology and Cutaneous Surgery What Determines Skin Color? What Determines Skin Color? No significant difference in the number of melanocytes between the races 2000 epidermal melanocytes/mm2 on head and forearm 1000 epidermal melanocytes/mm2 on the rest of the body differences present at birth Jimbow K, Quevedo WC, Prota G, Fitzpatrick TB (1999) Biology of melanocytes. In I. M. Freedberg, A.Z. Eisen, K. Wolff,K.F. Austen, L.A. Goldsmith, S. I. Katz, T. B. Fitzpatrick (Eds.), Dermatology in General Medicine 5th ed., pp192-220, New York, NY: McGraw Hill Melanosomes in Black and White Skin Black White Szabo G, Gerald AB, Pathak MA, Fitzpatrick TB. Nature1969;222:1081-1082 Jimbow K, Quevedo WC, Prota G, Fitzpatrick TB (1999) Biology of melanocytes. In I. M. Freedberg, A.Z. Eisen, K. Wolff, K.F. Austen, L.A. Goldsmith, S. I. Katz, T. B. Fitzpatrick (Eds.), Dermatology in General Medicine 5th ed., pp192- 220, New York, NY: McGraw Hill Role of Melanin-Advantages Melanin absorbs and scatters energy from UV and visible light to protect epidermal cells from UV damage Disadvantages Inflammation or injury to the skin is almost immediately accompanied by alteration in pigmentation Hyperpigmentation Hypopigmentation Dyschromias Post-Inflammatory hyperpigmentation Acne Melasma Lichen Planus Pigmentosus Progressive Macular Hypomelanosis
    [Show full text]
  • Melasma (1 of 8)
    Melasma (1 of 8) 1 Patient presents w/ symmetric hyperpigmented macules, which can be confl uent or punctate suggestive of melasma 2 DIAGNOSIS No ALTERNATIVE Does clinical presentation DIAGNOSIS confirm melasma? Yes A Non-pharmacological therapy • Patient education • Camoufl age make-up • Sunscreen B Pharmacological therapy Monotherapy • Hydroquinone or • Tretinoin TREATMENT Responding to No treatment? See next page Yes Continue treatment © MIMSas required Not all products are available or approved for above use in all countries. Specifi c prescribing information may be found in the latest MIMS. B94 © MIMS 2019 Melasma (2 of 8) Patient unresponsive to initial therapy MELASMA A Non-pharmacological therapy • Patient education • Camoufl age make-up • Sunscreen B Pharmacological therapy Dual Combination erapy • Hydroquinone plus • Tretinoin or • Azelaic acid Responding to Yes Continue treatment treatment? as required No A Non-pharmacological therapy • Patient education • Camoufl age make-up • Sunscreen • Laser therapy • Dermabrasion B Pharmacological therapy Triple Combination erapy • Hydroquinone plus • Tretinoin plus • Topical steroid Chemical peels 1 MELASMA • Acquired hyperpigmentary skin disorder characterized by irregular light to dark brown macules occurring in the sun-exposed areas of the face, neck & arms - Occurs most commonly w/ pregnancy (chloasma) & w/ the use of contraceptive pills - Other factors implicated in the etiopathogenesis are photosensitizing medications, genetic factors, mild ovarian or thyroid dysfunction, & certain cosmetics • Most commonly aff ects Fitzpatrick skin phototypes III & IV • More common in women than in men • Rare before puberty & common in women during their reproductive years • Solar & ©ultraviolet exposure is the mostMIMS important factor in its development Not all products are available or approved for above use in all countries.
    [Show full text]
  • Background on Multiple Births
    National Maternity and Perinatal Audit NHS Maternity Care for Women with Multiple Births and Their Babies A study on feasibility of assessing care using data from births between 1 April 2015 and 31 March 2017 in England, Wales and Scotland The National Maternity and Perinatal Audit (NMPA) is led by the Royal College of Obstetricians and Gynaecologists (RCOG) in partnership with the Royal College of Midwives (RCM), the Royal College of Paediatrics and Child Health (RCPCH) and the London School of Hygiene and Tropical Medicine (LSHTM). The NMPA is commissioned by the Healthcare Quality Improvement Partnership (HQIP) as part of the National Clinical Audit and Patient Outcomes Programme (NCAPOP) on behalf of NHS England, the Welsh Government and the Health Department of the Scottish Government. HQIP is led by a consortium of the Academy of Medical Royal Colleges, the Royal College of Nursing, and National Voices. Its aim is to promote quality improvement in patient outcomes, and in particular, to increase the impact that clinical audit, outcome review programmes and registries have on healthcare quality. HQIP holds the contract to commission, manage and develop the NCAPOP, comprising around 40 projects covering care provided to people with a wide range of medical, surgical and mental health conditions. The programme is funded by NHS England, the Welsh Government and, with some individual projects, other devolved administrations and crown dependencies (www.hqip.org.uk/national-programmes). © 2020 Healthcare Quality Improvement Partnership (HQIP)
    [Show full text]
  • Frequency of Different Types of Facial Melanoses Referring to the Department of Dermatology and Venereology, Nepal Medical Colle
    Amatya et al. BMC Dermatology (2020) 20:4 https://doi.org/10.1186/s12895-020-00100-3 RESEARCH ARTICLE Open Access Frequency of different types of facial melanoses referring to the Department of Dermatology and Venereology, Nepal Medical College and Teaching Hospital in 2019, and assessment of their effect on health-related quality of life Bibush Amatya* , Anil Kumar Jha and Shristi Shrestha Abstract Background: Abnormalities of facial pigmentation, or facial melanoses, are a common presenting complaint in Nepal and are the result of a diverse range of conditions. Objectives: The objective of this study was to determine the frequency, underlying cause and impact on quality of life of facial pigmentary disorders among patients visiting the Department of Dermatology and Venereology, Nepal Medical College and Teaching Hospital (NMCTH) over the course of one year. Methods: This was a cross-sectional study conducted at the Department of Dermatology and Venereology, NMCT H. We recruited patients with facial melanoses above 16 years of age who presented to the outpatient department. Clinical and demographic data were collected and all the enrolled participants completed the validated Nepali version of the Dermatology Life Quality Index (DLQI). Results: Between January 5, 2019 to January 4, 2020, a total of 485 patients were recruited in the study. The most common diagnoses were melasma (166 patients) and post acne hyperpigmentation (71 patients). Quality of life impairment was highest in patients having melasma with steroid induced rosacea-like dermatitis (DLQI = 13.54 ± 1.30), while it was lowest in participants with ephelides (2.45 ± 1.23). Conclusion: Facial melanoses are a common presenting complaint and lead to substantial impacts on quality of life.
    [Show full text]
  • Print) • Page 2 of 5
    Page 1 of 5 Are twins always high risk? • aims.org.uk Are twins always high risk? AIMS Journal, 2011, Vol 23 No 4 Joanne Whistler asks whether they are really a variation on normal After a wonderful home birth with my firstborn, Oliver, in 2006 I felt confident in my body's ability to labour and give birth. Even when I discovered that I was pregnant with twins late last year I had the attitude that it was just a variation on normal. It was only when I started reading up about multiple pregnancy and birth that my belief that I would have another good experience began to falter. Everything I read said that multiple pregnancies were higher risk, that I should expect a more medicalised experience of pregnancy and birth than a mother of a singleton, and implied that for my babies' sake I should give up any thought of what I considered to be a normal birth. Of course I wanted my babies to be safe, but I also wanted their entry into the world to be gentle and unmedicated – I was very aware of the risks and side effects of pharmacological pain relief and interventions such as induction. In the end I had a fabulous home water birth attended by two independent midwives. My husband and a trusted friend were also there. My midwife monitored the babies intermittently and removed the caul from twin two's face but otherwise my labour and birth were completely intervention-free. In this article I will discuss the evidence base for management of multiple pregnancies and explore some aspects of planning the birth of twins or more.
    [Show full text]
  • Skin Care, Hair Care and Cosmetic Treatments in Pregnancy and Breastfeeding
    Skin Care, Hair Care and Cosmetic Treatments in Pregnancy and Breastfeeding Information in this leaflet is general in nature and should not take the place of advice from your health care provider. With every pregnancy there is a 3 to 5% risk of having a baby with a birth defect. Issues for pregnancy Many pregnant women have skin and hair concerns just as they did before pregnancy. Sometimes conditions such as acne actually worsen during pregnancy because of hormonal changes and often women notice darkening of their skin (melasma). However, due to concern about potentially hazardous exposures to their unborn babies, pregnant women are often uncertain about which products are safe for them to use. Generally cosmetic treatments are discretionary (not medically necessary) and if safety is uncertain, women should consider whether the product or treatment is really required. There are several considerations when evaluating whether a specific skin or hair product is unsafe in pregnancy. Firstly, the active ingredient in the product needs to be considered unsafe. Secondly, it also has to be able to reach the unborn baby in its mother’s womb by inhalation or absorption through the mother’s skin (topical application). Although there is often limited information about the actual safety of specific ingredients in skin products during pregnancy, if it is known that skin absorption is minimal then the exposure to the unborn baby is generally insignificant and the product or treatment is regarded as safe. Below is a summary of current advice. Cosmetics, Moisturisers and other Skin Care Products Cosmetics and over the counter skin products generally contain ingredients that are unlikely to be harmful in pregnancy as they are used by applying to the skin (rather than swallowing a tablet).
    [Show full text]
  • Multiple Births
    Multiple Births A Parent Information Leaflet WhatWhat will will happen happen when when you firstyou discover first discover you are expectingyou are twins orexpecting more? twins or more? If you are expecting two or more babies at one time this is called a multiple pregnancy. This happens to about 1 in 65 women. This leaflet will help you and your partner understand more about your multiple pregnancy and help you make informed choices about the care you will receive in your pregnancy. This leaflet mostly refers to twin pregnancies as these are more common, but the issues are relevant to any multiple pregnancies (triplets, quadruplets). WhatWhat will will happen happen at my at Datingmy Dating Scan? Scan? The sonographer (the person performing the scan) will be checking to see: 1 How many babies you are carrying 2 If your babies are in separate or singlesacs 3 Whether they share a placenta (this is important as it will influence your antenatal care) 4 How many weeks into your pregnancy you are. You will be given a booklet on options for screening specifically for multiple births. WhatWhat Screening Screening will will I be Ioffered? be offered? As part of your antenatal care you will be offered a number of specialist screening and diagnostic tests to check for abnormalities in your babies. Please read the leaflet; ‘Screening for Down’s syndrome in twin pregnancies’ which was given to you by the sonographer. If you have any further questions please speak with your midwife or contact our specialist screening midwife on 07876 357423. A copy of the leaflet can be downloaded on the trust website mypregnancymatters.org.uk 2 If you are booked to have your babies at the Royal Sussex County Hospital (RSCH).
    [Show full text]
  • Multiple Perspective Discussion Paper
    Multiple perspectives: What support do multiple birth families need to live happy and healthy lives? This discussion paper is a compilation of case studies and opinions collected from Twins Research Australia’s collaborators. It provides a wide-ranging overview of issues and challenges for families and health professionals during pregnancy, birth and the early life of twins and multiples. Its aim is to initiate further discussions and explorations, and it provides recommendations for research, education, policy and practice. Acknowledgements This paper is a collaboration of Twins Research Australia, the Twins and Multiple Births Association (TAMBA – UK), the Australian Multiple Birth Association (AMBA) and the International Council of Multiple Birth Organisations (ICOMBO). Authors We wish to thank the following authors of papers included in this publication: Ashlee Tenberge - Australian Multiple Birth Association Christie Bolch - Murdoch Children’s Research Institute, Melbourne Helen Turier - Twins and Multiple Births Association (UK) Janet Young - City of Kingston Council, Victoria Jeff Craig - Deakin University, Victoria Joanna Fitzsimons - Twins and Multiple Births Association (UK) Keith Reed - Twins and Multiple Births Association (UK) Kelly McDonald - Twins and Multiple Births Association (UK) Marie Claire Stear - Twins and Multiple Births Association (UK) Mark Umstad - Melbourne Royal Women’s Hospital Monica Rankin - International Council of Multiple Birth Organisations Natasha Fenwick - Twins and Multiple Births Association (UK) Nikki Roberts - Twins and Multiple Births Association (UK) We also wish to acknowledge the work of Lucas Calais Ferreira and Twins Research Australia’s team in coordinating the contributions and content. Further enquiries: Twins Research Australia School of Population and Global Health The University of Melbourne Level 3, 207 Bouverie Street, Carlton Victoria 3010 Australia Email enquiries [email protected] © First printed April 2019 For citation: Twins Research Australia (TRA).
    [Show full text]
  • A New Insight on Atopic Skin Diathesis: Is It Correlated with the Severity of Melasma
    A New Insight on Atopic Skin Diathesis: Is It Correlated with the Severity of Melasma Danar Wicaksono1*, Rima Mustafa2, Sri Awalia Febriana1, Kristiana Etnawati1 1 Dermatovenereology Department, Faculty of Medicine Universitas Gadjah Mada – Dr. Sardjito General Hospital, Yogyakarta-Indonesia 2 Clinical Epidemiology and Biostatistics Unit, Faculty of Medicine Universitas Gadjah Mada –Dr. Sardjito General Hospital, Yogyakarta-Indonesia Keywords: Melasma, atopic skin diathesis (ASD), MASI score, atopic dermatitis (AD) Abstract: Melasma is a macular lesion of light brown to dark on the sun-exposed area, especially on the face. Atopic Skin Diathesis (ASD) is a clinical term to describe skin atopics with previous, present or future atopic dermatitis (AD). Dennie-Morgan infraorbital folds are secondary creases in the skin below the lower eyelids with a sensitivity of 78% and a specificity of 76% to diagnose AD. Melasma skin is characterized by impaired stratum corneum integrity and a delayed barrier recovery rate. Barrier dysfunction will stimulate keratinocyte to secrete keratinocyte-derived factor, which plays role in skin pigmentation process in melasma. To analyze correlation between ASD and Melasma Area Severity Index (MASI) score in melasma patient. This study is an observational analytic study with cross sectional design. Measurement of ASD and MASI score were done in 60 subjects with melasma who went to dermatology outpatient clinic Dr. Sardjito General Hospital from July 2017 to Januari 2018. The correlation between ASD and MASI score was analyzed using Pearson correlation. The result of this study showed no significant correlation between ASD and MASI scores (r: 0.02, p: 0,85). Crude Relative Risk (RR) for Dennie-Morgan infraorbital folds and MASI score was 4 (1.01-15.87).
    [Show full text]
  • 00005721-201907000-00003.Pdf
    2.0 ANCC Contact Hours Angela Y. Stanley, DNP, APRN-BC, PHCNS-BC, NEA-BC, RNC-OB, C-EFM, Catherine O. Durham, DNP, FNP-BC, James J. Sterrett, PharmD, BCPS, CDE, and Jerrol B. Wallace, DNP, MSN, CRNA SAFETY OF Over-the-Counter MEDICATIONS IN PREGNANCY Abstract Approximately 90% of pregnant women use medications while they are pregnant including both over-the-counter (OTC) and prescription medications. Some medica- tions can pose a threat to the pregnant woman and fetus with 10% of all birth defects directly linked to medications taken during pregnancy. Many medications have docu- mented safety for use during pregnancy, but research is limited due to ethical concerns of exposing the fetus to potential risks. Much of the information gleaned about safety in pregnancy is collected from registries, case studies and reports, animal studies, and outcomes management of pregnant women. Common OTC categories of readily accessible medications include antipyretics, analgesics, nonsteroidal anti- infl ammatory drugs, nasal topicals, antihistamines, decongestants, expectorants, antacids, antidiar- rheal, and topical dermatological medications. We review the safety categories for medications related to pregnancy and provide an overview of OTC medications a pregnant woman may consider for management of common conditions. Key words: Pharmacology; Pregnancy; Safety; Self-medication. Shutterstock 196 volume 44 | number 4 July/August 2019 Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved. he increased prevalence of pregnant women identifi ed risks in animal-reproduction studies or completed taking medications, including over-the-counter animal studies show no harm. The assignment of Category (OTC) medications presents a challenge to C has two indications; (1) limited or no research has been nurses providing care to women of childbear- conducted about use in pregnancy, and (2) animal studies ing age.
    [Show full text]
  • Multiple Pregnancy – Care Pathway
    Multiple Pregnancy – Care Pathway This care pathway covers the level of care you should be offered from the time of your first hospital scan, in addition to the routine care that is offered to all women during pregnancy. It aims to reduce risks and improve outcomes for you and your babies. Ideally you should be seen by a specialist team, who have more knowledge about multiple pregnancies, all the time. This would include a midwife, sonographer and doctor. This pathway is based on national best practice and hospitals receive extra funding to look after multiple pregnancies. If you are not receiving the care you would expect please raise it with the PALS team (patient liaison) at your hospital and let us know – [email protected] . We can then liaise with the hospital regarding the correct level of care that should be offered. Feel free to share this with your midwifery team and use it as a checklist for each appointment. Different Types of Multiple Pregnancy There are different types of multiple pregnancy so each care pathway is slightly different. Twins can be dichorionic (they have separate placentas) or monochorionic (they share a placenta). Triplets have a few possible combinations: Trichorionic – each baby has a separate placenta Dichorionic – two of the babies share a placenta and the third baby is separate Monochorionic – all three babies share a placenta It is possible for twins and triplets to share an amniotic sac as well as a placenta. Although rare, these pregnancies need extra care, closer monitoring by a specialist and an individual care pathway.
    [Show full text]
  • A Guide to Obstetrical Coding Production of This Document Is Made Possible by Financial Contributions from Health Canada and Provincial and Territorial Governments
    ICD-10-CA | CCI A Guide to Obstetrical Coding Production of this document is made possible by financial contributions from Health Canada and provincial and territorial governments. The views expressed herein do not necessarily represent the views of Health Canada or any provincial or territorial government. Unless otherwise indicated, this product uses data provided by Canada’s provinces and territories. All rights reserved. The contents of this publication may be reproduced unaltered, in whole or in part and by any means, solely for non-commercial purposes, provided that the Canadian Institute for Health Information is properly and fully acknowledged as the copyright owner. Any reproduction or use of this publication or its contents for any commercial purpose requires the prior written authorization of the Canadian Institute for Health Information. Reproduction or use that suggests endorsement by, or affiliation with, the Canadian Institute for Health Information is prohibited. For permission or information, please contact CIHI: Canadian Institute for Health Information 495 Richmond Road, Suite 600 Ottawa, Ontario K2A 4H6 Phone: 613-241-7860 Fax: 613-241-8120 www.cihi.ca [email protected] © 2018 Canadian Institute for Health Information Cette publication est aussi disponible en français sous le titre Guide de codification des données en obstétrique. Table of contents About CIHI ................................................................................................................................. 6 Chapter 1: Introduction ..............................................................................................................
    [Show full text]